Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 29 of 37
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Kanwa to acquire Midatech Pharma US

The initial consideration for the sale and transfer of the entire common stock of MTP US is $13.0 million, payable upon Closing, with up to $6m available by

Alexion to buy Syntimmune in $1.2bn deal

Based in Boston of Massachusetts, Syntimmune is engaged in the development of differentiated drug candidates in a range of autoimmune diseases. As per terms of the deal, Alexion